Chris specialises in complex cross-border M&A, private equity investments, fundraisings, restructurings and joint ventures. Chris also has particular experience advising on limited liability partnership and limited partnership matters.

He acts for clients including private equity sponsors, management teams, family offices and corporates.  He regularly acts for US-based clients investing in the UK. Chris has also acted for the UK Government on matters including the establishment of The British Business Bank and the establishment of the UK International Climate Fund.

Chris advises clients across a broad range of sectors, with a focus on financial services, life sciences and energy and infrastructure. He is especially interested in the cross-over between these sectors and innovative technological solutions.

Clients describe Chris as technically excellent, creative and focussed on providing pragmatic and commercial advice.

Chris is listed as a key lawyer in Taylor Wessing's M&A team in Legal 500.

CV ansehen CV ausblenden

Aktuelle News & Insights

Life Sciences & Healthcare

Advising Apollo Therapeutics on $145 million financing

21. Juni 2021

von Andrew Edge und Chris Cowley

Klicken Sie hier für Details
Technology, Media & Communications

All change for the Online Safety Bill?

18. Januar 2022

von Adam Rendle und Xuyang Zhu

Klicken Sie hier für Details
Life Sciences & Healthcare

Conference series widens investor access to cutting-edge healthcare stocks

18. Januar 2022

von Ross McNaughton

Klicken Sie hier für Details
UPC

It is time to think about UPC opt-out again: how it is achieved and its strategic implications

Part 2

17. Januar 2022
In-depth analysis

von mehreren Autoren

Klicken Sie hier für Details

Meet me at

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.